Clinical characteristics of patients with COVID-19
Variable | Patients (n=12) |
Age (years) | 54 (36, 76) |
Male | 9 (75%) |
Median BMI (range) | 27 (22, 45) |
Comorbidities | |
Cardiac | 6 (50%) |
DM | 5 (42%) |
Asthma/COPD | 2 (17%) |
CKD | 4 (33%) |
Stroke | 0 (0%) |
Extubation trial | 5 (42%) |
Time to tracheostomy* (days) | 17 (10, 27) |
COVID-19 status prior to tracheostomy | |
Positive | 9 (75%) |
Negative | 1 (8%) |
Unknown | 2 (17%) |
Intraprocedural complication | 0 (0%) |
Postprocedure bleeding | 2 (17%) |
Tracheostomy decannulated | 5 (42%) |
Discharged from hospital | 8 (67%) |
Death | 4 (33%) |
Follow-up (weeks) | 5 (3, 16) |
Healthcare worker infection | 0 (0%) |
Data portrayed as either median (range) or n (%). Follow-up indicates number of weeks of follow-up since tracheostomy.
*Indicates time from initial intubation to tracheostomy placement.
BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.